You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Kinetic Phenotype Discovery Informatics for Neurological Diseases

    SBC: DRVISION TECHNOLOGIES LLC            Topic: 101

    Project Summary Neurological disorders significantly outnumber diseases in other therapeutic areas and are growing in incidence faster than any other disease classes However the pharmaceutical industry has been unsuccessful in coming up with effective drugs A big factor in these failures has been a lack of adequate model systems for fundamental disease understanding affecting both diagnosis and ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Computer based Screening for Diabetic Retinopathy

    SBC: VisionQuest Biomedical Inc            Topic: NEI

    Summary VisionQuest Biomedical LLC VisionQuest has developed a diabetic retinopathy DR screening system EyeStar enabled by automated screening software DR RACS that was developed under the EY Phase II SBIR project Our product provides immediate feedback to the physician on the state of diabetic eye disease without burdening an eye care specialist to review those cases without retin ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Cardiac Ventricular Assist Catheter

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: NICHD

    ABSTRACT Extracorporeal membrane oxygenation ECMO use continues to increase as a supportive measure for cardio respiratory failure Pediatric patients with severe acute left ventricular LV systolic dysfunction are often supported with venoarterial VA ECMO as a short term bridge to recovery transplant or a ventricular assist device VAD Although this often provides the much needed tempora ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. MiRNAs as serum biomarkers for T1D

    SBC: MIRNATECH INTERNATIONAL INC            Topic: NIDDK

    Abstract Prospective cohort studies in individuals at risk for Type diabetes T D have established that diagnosis of the disease occurs at a late stage in the progressive decline in cell function when the majority of cell function has been lost and the possibility for disease prevention is gone Current measures of autoantibodies HLA typing and oral glucose tolerance tests OGTT are abl ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. A method for early and easy detection of Alzheimer s disease

    SBC: NANOMEDIC INC            Topic: NIA

    Abstract Alzheimerandapos s disease AD is one of the leading causes of death among aged people and currently more than million people have AD in the US alone Although there is no cure for AD studies indicate that clinically proven medicines have the ability to slow ADandapos s progress especially if they are administered early on Obviously to develop diagnostics that are able to detect ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Transcutaneous Neuromodulation at Acupoint for Gastric Complications of Scleroderma

    SBC: TRANSTIMULATION RESEARCH INC            Topic: R

    DESCRIPTION provided by applicant Systemic sclerosis scleroderma SSc is a chronic autoimmune disease characterized by proliferative vascular lesions with resultant fibrosis of skin and other multiple organs including the gastrointestinal GI tract In the United States the prevalence of SSc is about per million in adults Up to of SSc patients are reported to have upper and lower ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Multi-channel MR-compatible flexible microelectrode for recording and stimulation

    SBC: BLACKROCK MICROSYSTEMS, INC            Topic: 101

    DESCRIPTIONprovided by applicantFunctional magnetic resonance imagingfMRIhas become one of the leading research tools to study brain function and is playing a pivotal role in several large scale brain mapping projects worldwideDespite ongoing technical advancements in MRI which have greatly increased its availability and helped improve the resolution for functional brain mappingwe still have very ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Oral Immunotherapy with IgA to Treat Clostridium difficile Infection

    SBC: SECRETORY IGA INC            Topic: 300

    Clostridium difficile infectionthe cause of antibiotic associated pseudomembraneous colitisis a growing national health problemThe incidence of primary Clostridium difficile infection in the hospitalized U Spopulation is greater thancases annuallyThere is a high incidence of relapseCdifficile infection is also a significant problem among patients with ulcerative colitisThis infection is often diff ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Optimization of a novel cancer immunotherapeutic antibody for human use

    SBC: CANCURE LLC            Topic: 102

    ABSTRACT The goal of this application is to evaluate the cancer therapeutic feasibility of CanCureandapos s humanized first in class immunostimulatory monoclonal antibody mAb huB G the Product also names CuraB During cancer development in response to oncogenic insult or stress almost ALL human cancer cells are induced to express a SURFACE molecule MIC MHC I chain related Molecule wh ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. New therapeutics targeting skeletal excessive Fe for thalassemia major bone loss

    SBC: NANOMEDIC INC            Topic: NICHD

    DESCRIPTION provided by applicant This is a SBIR Phase I application to develop new iron chelating drugs for prevention and treatment of iron overload induced bone loss in patients with thalassemia major TM a rare disease in the US Virtually all TM patients are affected by osteopenia and osteoporosis and these skeletal complications herald and contribute to a general clinical deterioratio ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government